Pharmaceutical formulations containing acrivastine

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5370880
SERIAL NO

08117985

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a controlled release pharmaceutical formulation for oral administration which comprises discrete units comprising acrivastine or a salt thereof coated with a mixture containing: a) a copolymer or polymer containing repeating monomer units selected from alkyl esters of acrylic and methacrylic acids and b) ethyl cellulose, and a process for preparing such formulations.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEDEVA CALIFORNIA INC3501 WEST GARRY AVENUE SANTA ANA CA 52704

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gamlen, Michael J D Dartford, GB2 4 70
Jones, Harry P Dartford, GB2 5 109
Mackey, Robert J Dartford, GB2 4 83

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation